4//SEC Filing
Inrig Jula 4
Accession 0001415889-24-023128
CIK 0001438533other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:05 PM ET
Size
5.2 KB
Accession
0001415889-24-023128
Insider Transaction Report
Form 4
Inrig Jula
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2024-09-10$12.98/sh−684$8,878→ 61,949 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted March 15, 2024 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units that vested on September 5, 2024.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001902368
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:05 PM ET
- Size
- 5.2 KB